MedinCell S.A.
EPA:MEDCL.PA
Overview | Financials
Company Name | MedinCell S.A. |
Symbol | MEDCL.PA |
Currency | EUR |
Price | 17.6 |
Market Cap | 511,960,170 |
Dividend Yield | 0% |
52-week-range | 5.85 - 19 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Christophe Douat |
Website | https://www.medincell.com |
An error occurred while fetching data.
About MedinCell S.A.
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD